Fresenius Medical Care AG
XMUN:FME

Watchlist Manager
Fresenius Medical Care AG Logo
Fresenius Medical Care AG
XMUN:FME
Watchlist
Price: 48.38 EUR 0.96%
Market Cap: 28.4B EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one FME stock under the Base Case scenario is 64.89 EUR. Compared to the current market price of 48.38 EUR, Fresenius Medical Care AG is Undervalued by 25%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FME Relative Value
Base Case
64.89 EUR
Undervaluation 25%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
46
vs Industry
57
Median 3Y
1.2
Median 5Y
1.4
Industry
2.2
Forward
1.4
More Details
45.9
P/E
P/E
Price to Earnings
45.9
vs History
14
vs Industry
10
Median 3Y
41.4
Median 5Y
37.5
Industry
21.9
Forward
26.1
More Details
11.7
P/OCF
P/OCF
Price to OCF
11.7
vs History
28
vs Industry
33
Median 3Y
10
Median 5Y
10
Industry
14.1
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
1
Median 3Y
33
Median 5Y
30.4
Industry
19.8
More Details
2
P/B
P/B
Price to Book Value
2
vs History
44
vs Industry
45
Median 3Y
1.6
Median 5Y
1.9
Industry
2.1
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
47
vs Industry
51
Median 3Y
1.7
Median 5Y
1.9
Industry
2.4
Forward
1.8
More Details
7.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.7
vs History
42
vs Industry
30
Median 3Y
6.5
Median 5Y
7.4
Industry
4.9
More Details
12.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.1
vs History
34
vs Industry
30
Median 3Y
10.3
Median 5Y
11.6
Industry
11.5
Forward
10
More Details
26.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
26.1
vs History
22
vs Industry
16
Median 3Y
24.6
Median 5Y
23.9
Industry
15.7
Forward
17.4
More Details
15.1
EV/OCF
EV/OCF
Enterprise Value to OCF
15.1
vs History
34
vs Industry
28
Median 3Y
14.3
Median 5Y
14.3
Industry
14.1
More Details
21.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
21.7
vs History
39
vs Industry
22
Median 3Y
20.6
Median 5Y
20.6
Industry
17.6
More Details
1.2
EV/IC
EV/IC
Enterprise Value to IC
1.2
vs History
42
vs Industry
55
Median 3Y
1
Median 5Y
1.2
Industry
1.8
More Details

Multiples Across Competitors

FME Competitors Multiples
Fresenius Medical Care AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Fresenius Medical Care AG
XMUN:FME
28.4B EUR 1.5 45.9 12.1 26.1
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 17.6 8.6 11.1
US
Cigna Corp
NYSE:CI
88.1B USD 0.3 17.5 8.6 11
US
CVS Health Corp
NYSE:CVS
86.4B USD 0.2 16.4 13.3 13.3
MY
Alpha IVF Group Bhd
KLSE:ALPHA
278.5B MYR 1 661.7 5 261 3 517.5 3 822.2
DE
Fresenius SE & Co KGaA
XETRA:FRE
24B EUR 1.1 56.9 10.4 16.8
US
Laboratory Corporation of America Holdings
NYSE:LH
21.8B USD 1.7 29.9 15.1 23.7
US
Quest Diagnostics Inc
NYSE:DGX
19.9B USD 2 22.3 13 17.5
MY
Hong Seng Consolidated Bhd
KLSE:HONGSENG
71.1B MYR 2 664.9 -1 599.3 -1 017.8 -1 017.8
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
14.2B EUR 0.7 22.9 7.4 15.9
US
Hims & Hers Health Inc
NYSE:HIMS
11B USD 6.2 67.2 77.8 92.8

See Also

Summary
FME intrinsic value, competitors valuation, and company profile.
DCF Valuation
FME stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FME stock valuation using valuation multiples.
Wall Street Estimates
FME price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FME stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 264,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.